Press

  • October 2008: Biofutur, “ProtNeteomix mise sur de nouvelles technologies”.
  • September 2008: Funakoshi News, “MAGYarray antibody array.”
  • July 2008: European Biopharmaceutical review, “Cost-effective Microarray-Based Solutions for Drug Discovery & Development”.
  • July 2008: Atlantic Biotherapies Newsletter, N°21, “ProtNeteomix un bilan encourageant à l’international”.
  • June 2008: La lettre API, N°752.
  • March 2008: European Biopharmaceutical Review, “ProtNeteomix proposes cost-efficient microarray based solutions for DDD”.
  • March 2008: Clinical and Experimental Allergy, “Assessment of the immunoglobulin E-mediated immune response to milk-specific proteins in allergic patients using microarrays”.
  • September 2007: Ouest France, “Europe unites against bacterium”.
  • February 2006: Biotech Finances, “ProtNeteomix commercialises its first bioarray”.
  • January 2006: Genetic Engineering News, “Drug Discovery: Protein Profiling Poised to Make its Mark”.
  • January/february 2005: Business Reference, “ProtNeteomix fights against cancer”.
  • January 2005: Publibusiness, “ProtNeteomix fights against cancer”.
  • November 2004: BIOTECHINFO – L’Usine Nouvelle
  • February 2003: L’Expansion, “Les 10 chercheurs qui dopent l’industrie”.
  • 5 December 2002: La gazette du laboratoire n°73, “De nouvelles technologies pour la post-génomique et la protéomique”.
  • 5 December 2002: L’Usine Nouvelle – publiscopie, “ProtNeteomix propose des solutions innovantes”.